AEGiS-07CROI: Cumulative time-dependent probability of developing fat tissue alterations in female patients treated with combined antiretroviral therapy.

7th Conference on Retroviruses and Opportunistic Infections

San Francisco, CA - January 30 -February 4, 2000

CUMULATIVE TIME-DEPENDENT PROBABILITY OF DEVELOPING FAT TISSUE ALTERATIONS IN FEMALE PATIENTS TREATED WITH COMBINED ANTIRETROVIRAL THERAPY.

Conf Retroviruses Opportunistic Infect 2000 Jan 30-Feb 2; 7:80 (abstract no. 28)

M. Galli¹, A. L. Ridolfo¹, L. Ravasio¹, C. Gervasoni¹, L. Corsico¹, F. Adorni², S. Santambrogio¹, A. D’Arminio Monforte¹, And M. Moroni¹
¹Inst. Infectious Diseases & Tropical Med., Univ. Milano, ²ITBA-CNR, Milano, Italy

BACKGROUND: Fat tissue alterations (FTA), including fat accumulation (FA), fat redistribution (FR) and lipodystrophy (LD), are frequently observed in patients (pts) treated with antiretroviral therapy (ART). Moreover, some evidences suggest a higher incidence of FR in females.

METHODS: We performed a observational study in a cohort of female pts consecutively recruited since November 1997 analyzing the time-dependent cumulative probability of developing FTA according to the drug combination administered .

RESULTS: At enrollment, FTA was present in 39/321 pts (12.1%). FR was the most common alteration (36/39, 92.3%) while LD was observed in only 2 cases. By April 1999, 107/309 pts (34.6%) still in follow up presented with FTA: 53 FR, 25 FA and 28 LD. A remission of FR and its evolution in localized FA was observed in 7 and 2 cases, respectively, after treatment withdrawal (n=2) or after changing one or more drugs (n=7); in 4 cases FR evolved in LD under initial treatment(n=2) or after changing one or more drugs (n=2). The cumulative probability of developing FTA in PI-treated pts (considering also the pre-study period of treatment) was 29.8% after 1 year of follow up and 44.4% after two years, while the probability of developing LD was 7.1% after 1 year and increased to 10% after 2 years. Intention to treat analysis in pts treated with 2 NRTIs at enrollment did not evidence a significantly different cumulative probability of developing FTA after 1 year of follow up in pts treated with ZDV containing- and d4T-containing-regimens (21% vs 28%). The probability of developing LD in the two groups was 5.5% and 8.5%, respectively.

CONCLUSIONS: FTA is a frequent untoward effect of ART in females. FR, including breast enlargement in the majority of cases, is the earliest manifestation and frequently occurs also in pts not receiving PIs. LD generally needs longer period of treatment to develop and may be observed also PI-naïve pts treated with NRTI combinations.

Keywords: AEGIS, Adipose Tissue, Stavudine, Lipodystrophy, Anti-HIV Agents, Reverse Transcriptase Inhibitors, HIV Protease Inhibitors, Zidovudine, Probability, Risk Factors, Obesity, Human, Female, AIDS

2000-01-30
28

Copyright © 2000 - Foundation for Retrovirology and Human Health (IAS). Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Foundation for Retrovirology and Human Health. Licensed from National Library of Medicine.